Stanford University
Showing 1-50 of 2,429 Results
-
Fahim Abbasi
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioDr. Fahim Abbasi specializes in diagnosis and treatment of prediabetes and insulin resistance. Dr. Abbasi has a special interest in prevention of diabetes and cardiovascular disease through lifestyle modifications.
-
Gita Chu Abhiraman
Affiliate, Department Funds
Resident in MedicineBioGita Abhiraman is a resident physician in Internal Medicine at Stanford in the Translational Investigator Program. She completed her MD and PhD at Stanford in the Medical Scientist Training Program. Her PhD in Immunology was advised by Dr. Chris Garcia, in which she studied cytokine signaling, immune receptor structure, and protein engineering. Her major first author-works include solving the structure of the interleukin-21 signaling receptor complex. She also developed a cytokine "adapter" switch molecule with applications in cancer and autoimmune disease. Gita has been involved in several projects to engineer cytokines, including IL-21, IL-12, and IL-10, for diverse therapeutic applications. Prior to her graduate training, Gita completed a bachelor's degree in Physics with a focus in Biophysics at Harvard University. She previously conducted research in the lab of Dr. Stephanie Dougan at the Dana-Farber Cancer Institute.
-
Ranjana Advani
Saul A. Rosenberg, MD, Professor of Lymphoma
Current Research and Scholarly InterestsClinical investigation in Hodgkin's disease, non-Hodgkin's Lymphomas and cutaneous lymphomas. Experimental therapeutics with novel chemotherapy and biologically targeted therapies.
The research program is highly collaborative with radiation oncology, industry, pathology and dermatology. -
Solmaz Ehteshami Afshar, MD
Clinical Assistant Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
BioDr. Ehteshami Afshar is a board-certified, fellowship-trained pulmonologist with Stanford Health Care. She is also a clinical assistant professor in the Department of Medicine, Division of Pulmonary, Allergy & Critical Care Medicine at Stanford University School of Medicine. She earned her MSc from the University of British Columbia, specializing in health economics, before completing her residency in internal medicine at Yale New Haven Hospital. She furthered her training at Stanford University, pursuing fellowships in pulmonary and critical care medicine as well as sleep medicine.
Dr. Ehteshami Afshar’s clinical expertise lies in the management of complex pulmonary conditions and sleep-related respiratory disorders, with a particular focus on patients with neuromuscular diseases. She diagnoses and treats acute and chronic respiratory failure requiring noninvasive home mechanical ventilation, sleep-related respiratory disorders including sleep apnea, and airway disease including asthma and chronic obstructive pulmonary disease (COPD). She also provides care for critically ill patients in the intensive care units (ICU).
Dr. Ehteshami Afshar’s current research interests include improving the respiratory status of patients with amyotrophic lateral sclerosis (ALS) as well as identifying novel treatment options for patients with tracheobronchomalacia. She has previously worked on research studies on COPD care, asthma interventions, and patient education around asthma.
Dr. Ehteshami Afshar has published her research in many peer-reviewed journals, including the American Journal of Respiratory and Critical Care Medicine, Respiratory Research, and Cleveland Clinic Journal of Medicine. She has presented to her peers at international, national, and regional meetings, including the American College of Chest Physicians Annual Meeting, the American Thoracic Society International Conference, and the California Thoracic Society Annual Educational Conference. -
Patrick Ahearn, MD, MAS
Clinical Assistant Professor, Medicine - Nephrology
BioDr. Ahearn is a board-certified nephrologist. He is also a clinical assistant professor in the Stanford University School of Medicine Division of Nephrology.
He specializes in providing innovative care to kidney disease and transplant patients. He develops a comprehensive, compassionate care plan personalized to each patient in his care.
In addition to his clinical practice, Dr. Ahearn has conducted research on barriers to transplantation for patients with extended dialysis exposure, disparities in living kidney donation, and disparities in access to kidney transplant. He also has researched kidney transplant outcomes as they relate to the timing of dialysis initiation plus new pharmaceuticals for the kidney transplant population.
Dr. Ahearn has made presentations on these and other topics to the American Transplant Congress and Society of General Internal Medicine Meeting. He has published peer-reviewed articles on his research topics in the Clinical Journal of the American Society of Nephrology, JAMA Network Open, American Journal of Kidney Diseases, American Journal of Surgery, and elsewhere. He has published abstracts in the Journal of the American Society of Nephrology.
Dr. Ahearn has earned honors for his research and scholarship. He has received research funding from the National Institute of Diabetes and Digestive and Kidney Diseases.
Among his honors, Dr. Ahearn was on the kidney transplant team that earned the Stanford Health Care Integrated Strategic Plan Star Award. The team was recognized for delivering excellence in patient care as well as for identifying opportunities to improve care.
He is a member of the American Society of Nephrology and American Society of Transplantation.
He has volunteered his time and expertise as a board member of the Village of Hope, a transitional housing program for homeless men, women, and children in Orange County, California. Dr. Ahearn has served as a volunteer and proctor at the free clinic providing medical services to the uninsured. -
Aijaz Ahmed, MD
Professor of Medicine (Gastroenterology and Hepatology)
BioDr. Ahmed is an internationally recognized hepatologist with expertise in the treatment of acute and chronic liver diseases. He is a board-certified specialist in gastroenterology and hepatology, transplant hepatology, and obesity medicine. Currently, he serves as the Medical Director of the Adult Liver Transplant Program at Stanford University.
Dr. Ahmed graduated from Dow Medical College, Karachi, Pakistan. He completed his residency training in Internal Medicine at Brown University, Providence, RI and fellowship training in Gastroenterology and Hepatology at Stanford University. During his fellowship, he focused on clinical and research training in General and Transplant Hepatology.
For patients under his care, Dr. Ahmed remains dedicated to creating a personalized, comprehensive, and above-all a compassionate treatment plan. He outlines the diagnostic and follow-up management pathway in an individualized fashion; he updates his patients and their family/support at each step of the decision-making process; and he focuses on prioritizing the wishes of his patients and their family/support for an optimal outcome and quality of life.
Dr. Ahmed remains clinically active and has been instrumental in establishing a wide network of hepatology outreach clinics in remote and underserved regions of California and Nevada.
In addition to his patient care responsibilities, Dr. Ahmed remains committed to the educational mission of Stanford ford University. He remains deeply interested in mentoring trainees and students al levels from undergraduates to trainee physicians and junior colleagues. Dr. Ahmed has received several teaching awards during his career.
Dr. Ahmed’s research interests include 1) multidisciplinary approach to nonalcoholic fatty liver disease (NAFLD), 2) disparities in the management of chronic liver disease, 3) improving screening and management of hepatocellular carcinoma (HCC), and 4) outcomes research in NAFLD, HCC, viral hepatitis, alcoholic liver disease, and liver transplantation. He heads a busy and productive outcomes research team. In addition, he collaborates with basic scientists and is participating in several translational research projects at Stanford University.
He has published his findings in textbooks, abstracts, case reports, and high- profile medical journals including Gastroenterology, Journal of Hepatology, Hepatology American Journal of Gastroenterology, and other well-renowned peer-reviewed publications.
Dr. Ahmed and his team has made presentations to his peers at many national and international conferences: the American Association for the Study of Liver Disease, International Liver Congress, European Association for the Study of the Liver, Asian Pacific Association for the Study of the Liver, and more. His presentations have addressed leading-edge approaches to the treatment of chronic liver disease, liver cancer, and liver failure. He also has presented his insights into the gastrointestinal impact of COVID-19.
For his clinical, research, and teaching achievements, Dr. Ahmed has earned extensive recognition. His honors include being named as one of America’s Top Physicians by the Consumers’ Research Council of America.
He is an active member of the American Gastroenterological Association and the American Association for the Study of Liver Diseases. -
So Hee "Naomi" Ahn
Casual, Medicine - Med/Family and Community Medicine
BioNaomi is a fourth-year medical student at Seoul National University, expecting to graduate in February 2024. She earned her bachelor's degree Summa Cum Laude from Washington University in St. Louis in December 2018, majoring in Biology and minoring in Chinese Language & Culture. Although she has quite a long way to go before becoming a compassionate physician-scientist, Naomi has accumulated many years of research and clinical experience in the field of medicine, ranging from the molecular level to the population level. Her research interests lie in genomics, psychosomatic medicine, and global health.
-
Neera Ahuja
Professor of Medicine (Hospital Medicine)
Current Research and Scholarly InterestsClinical inpatient trials, Quality improvement, Assessing interventions with operations on throughput. SDOH/Health equity
Medical education research; Intergenerational teaching/learning; Analysis of effects of duty hour regulations on housestaff training and ways to improve the system -
Alawab Aldulimy
Clinical Rsch Coord Assoc, CV Med - Clinical Trials
Current Role at StanfordClinical Researcher
Clinical Research Coordinator -
William Alegria
Lecturer, Medicine - Med/Infectious Diseases
BioDr. Alegria is a board-certified Infectious Diseases Pharmacotherapy specialist and antimicrobial stewardship consultant with the Stanford Antimicrobial Safety and Sustainability Program. He primarily practices in the inpatient setting and is dedicated to developing targeted stewardship interventions in immunocompromised patient populations. His clinical interests include management of infections in immunocompromised hosts, antifungal pharmacotherapy, and difficult-to-treat infections.
Publications (selected)
Navigating recurrent Clostridioides difficile infection without Bezlotoxumab: potential challenges ahead. Arya R, Zimmet AN, Holubar M, Alegria W. Antimicrob Steward Healthc Epidemiol. 2025
How to leverage medication use evaluations for antimicrobial stewardship goals: a primer for physicians. Prasad R, Arya R, Meng L, Holubar M, Alegria W, Zimmet AN.
Antimicrob Steward Healthc Epidemiol. 2025
Beyond the basics: rethinking antimicrobial stewardship by targeting cytomegalovirus immune globulin for immunocompromised patients. Prasad R, Lu B, Veloria D, Mui E, Nelson J, Dhillon G, Deresinski S, Holubar M, Alegria W. Antimicrob Steward Healthc Epidemiol. 2025
No "One-Size-Fits All": chronic "Carryover" diagnoses dilute antibiotic prescribing rates for sinusitis among adults in primary and urgent care settings. Smith M, Hawkins M, Laikijrung C, Mui E, Alegria W, Leung T, Zimmet A, Ha D, Holubar M. Infect Control Hosp Epidemiol. 2024
Combination Antifungal Therapy for Invasive Mucormycosis in Immunocompromised Hosts: A Single-Center Experience. Lu B, Ha D, Shen S, Ferguson Toll J, Kim A, Kim S, Mui E, Deresinski S, Holubar M, Alegria W. Open Forum Infect Dis. 2024
"Electronic Phenotyping" Antimicrobials to Facilitate Outpatient Stewardship for Asymptomatic Bacteriuria and Urinary Tract Infection in Renal Transplant. Zimmet AN, Ha D, Mui E, Smith M, Hawkins M, Alegria W, Holubar M. Open Forum Infect Dis. 2024
Risk factors and outcomes associated with persistent vancomycin resistant Enterococcal Bacteremia. Fox E, Ha D, Bounthavong M, Meng L, Mui E, Holubar M, Deresinski S, Alegria W. BMC Infect Dis. 2022
Shorter durations of antibiotic therapy in organ transplant. Alegria W, Medvedeva N, Holubar M. Curr Opin Organ Transplant. 2022
Characterisation of infections in patients with acute myeloid leukaemia receiving venetoclax and a hypomethylating agent. On S, Rath CG, Lan M, Wu B, Lau KM, Cheung E, Alegria W, Young R, Tan M, Kim C, Phun J, Patel N, Mannis G, Logan AC, Kennedy V, Goodman A, Taplitz RA, Young PA, Wen R, Saunders IM. Br J Haematol. 2022
Early Antibiotic Discontinuation or De-escalation in High-Risk Patients With AML With Febrile Neutropenia and Prolonged Neutropenia. Alegria W, Marini BL, Gregg KS, Bixby DL, Perissinotti A, Nagel J. J Natl Compr Canc Netw. 2022
Effect of rapid methicillin-resistant Staphylococcus aureus nasal polymerase chain reaction screening on vancomycin use in the intensive care unit. Diep C, Meng L, Pourali S, Hitchcock MM, Alegria W, Swayngim R, Ran R, Banaei N, Deresinski S, Holubar M. Am J Health Syst Pharm. 2021 Dec
The Current State of Antifungal Stewardship in Immunocompromised Populations. Alegria W, Patel PK. J Fungi (Basel). 2021
Bacteremia due to Methicillin-Resistant Staphylococcus aureus: An Update on New Therapeutic Approaches. Holubar M, Meng L, Alegria W, Deresinski S. Infect Dis Clin North Am. 2020
Impact of Rapid Antimicrobial Susceptibility Testing in Gram-Negative Rod Bacteremia: a Quasi-experimental Study. Hogan CA, Ebunji B, Watz N, Kapphahn K, Rigdon J, Mui E, Meng L, Alegria W, Holubar M, Deresinski S, Banaei N. J Clin Microbiol. 2020
Antimicrobial Stewardship in Cancer Patients: The Time is Now. Aitken SL, Nagel JL, Abbo L, Alegria W, Barreto JN, Dadwal S, Freifeld AG, Jain R, Pergam SA, Tverdek FP, Seo SK; Antimicrobial Stewardship in Cancer Consortium ASCC. J Natl Compr Canc Netw. 2019 -
Kevin M. Alexander, MD, FACC, FHFSA
Assistant Professor of Medicine (Cardiovascular Medicine)
BioDr. Alexander is an advanced heart failure-trained cardiologist. He is also an Assistant Professor of Cardiovascular Medicine at Stanford University School of Medicine.
Dr. Alexander specializes in the management of advanced heart failure and transplant cases, seeing a wide range of patients. He also has an active research laboratory, studying various forms of heart failure.
Dr. Alexander has expertise in diagnosing and treating transthyretin cardiac amyloidosis, a critical yet underdiagnosed cause of heart failure among African Americans and the elderly. He is conducting extensive research to enhance our understanding of this condition, with grant support from the National Institutes of Health and American Heart Association, among other sources. -
Ash A. Alizadeh, MD/PhD
Moghadam Family Professor
Current Research and Scholarly InterestsMy research is focused on attaining a better understanding of the initiation, maintenance, and progression of tumors, and their response to current therapies toward improving future treatment strategies. In this effort, I employ tools from functional genomics, computational biology, molecular genetics, and mouse models.
Clinically, I specialize in the care of patients with lymphomas, working on translating our findings in prospective cancer clinical trials. -
Matthew S Alkaitis, MD PhD
Clinical Assistant Professor, Medicine
BioMatthew S Alkaitis MD, PhD is a Clinical Assistant Professor in the Division of Hospital medicine and Stanford School of Medicine. He received his PhD in biochemistry from the University of Oxford, in collaboration the National Institutes of Health as part of the NIH’s graduate partnership program. He received his MD from Harvard Medical school and completed his residency in internal medicine at Stanford. Dr. Alkaitis’ research interests span basic biochemistry, clinical informatics, natural language processing, genetics of hematologic malignancies and methods of cell-free DNA detection. His primary medical education interest is expanding accessibility of modern computational and bioinformatics techniques for clinical research.
